{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:33:25Z","timestamp":1794522805006,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013076","name":"national major science and technology projects of china","doi-asserted-by":"publisher","award":["2014ZX10005001"],"award-info":[{"award-number":["2014ZX10005001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"beijing nova program","doi-asserted-by":"publisher","award":["Z201100006820051"],"award-info":[{"award-number":["Z201100006820051"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12072-021-10277-5","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T09:23:12Z","timestamp":1645435392000},"page":"614-626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGF\u03b2 receptor 1"],"prefix":"10.1007","volume":"16","author":[{"given":"Yanhua","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-4703","authenticated-orcid":false,"given":"Xiaoxue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-9669","authenticated-orcid":false,"given":"Huichun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"10277_CR1","unstructured":"Organization WH (2017) Global Hepatitis Report, 2017 (Global Hepatitis Report, 2017)."},{"key":"10277_CR2","first-page":"938","volume":"27","author":"Chinese, Society, Of, Infectious, Diseases, Chinese, Medical, Association, Chinese, and Society","year":"2019","unstructured":"Chinese, Society, Of, Infectious, Diseases, Chinese, Medical, Association, Chinese, and Society. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Chin J Hepatol. 2019;27:938\u2013961","journal-title":"Chin J Hepatol"},{"key":"10277_CR3","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62:S15\u2013S24","journal-title":"J Hepatol"},{"key":"10277_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/1471-2105-11-419","volume":"11","author":"L Ming","year":"2010","unstructured":"Ming L, Shi B, Wang J, Cao Q, Cui Q. TAM: A method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinform. 2010;11:419","journal-title":"BMC Bioinform"},{"key":"10277_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"10","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;10:997\u20131006","journal-title":"Cell Res"},{"key":"10277_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"S Margaret","year":"2012","unstructured":"Margaret S, Ert E, Phillip AS. Roles for MicroRNAs in conferring robustness to biological processes-ScienceDirect. Cell. 2012;149:515\u2013524","journal-title":"Cell"},{"key":"10277_CR7","unstructured":"Lilla R, Correspondence A, Hardy R. RNA samples at present is the RNA Integrity Number (RIN) as calculated by the Agilent 2100 Bioanalyzer for electro- phoresis (Agilent Technologies UK Ltd, Edinburgh, UK)."},{"key":"10277_CR8","doi-asserted-by":"crossref","unstructured":"Zheng Y, Xu Q, Chen H, Chen Q, Gong Z, Lai W. Transcriptome analysis of ultraviolet A\u2010induced photoaging cells with deep sequencing. J Dermatol 2017.","DOI":"10.1111\/1346-8138.14157"},{"key":"10277_CR9","first-page":"16552","volume":"5","author":"HY Li","year":"2015","unstructured":"Li HY, Ju D, Zhang DW, Li H, Kong LM, Guo Y, et al. Activation of TGF-\u03b21-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis. Rep. 2015;5:16552","journal-title":"Rep"},{"key":"10277_CR10","doi-asserted-by":"crossref","unstructured":"Friedlnder MR, Mackowiak SD, Li N, Chen W, Nikolaus R. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 2012;37\u201352.","DOI":"10.1093\/nar\/gkr688"},{"key":"10277_CR11","doi-asserted-by":"crossref","unstructured":"Ming-liang J, Jun L, Pei-liang S, Xue-jun Z, Shan-zheng W. Dysregulated miR-98 Contributes to Extracellular Matrix Degradation by Targeting IL-6\/STAT3 Signaling Pathway in Human Intervertebral Disc Degeneration. J Bone Miner Res 2015; 900\u2013909.","DOI":"10.1002\/jbmr.2753"},{"key":"10277_CR12","doi-asserted-by":"crossref","unstructured":"Zhang BY, Zhao Z, Jin Z. Expression of miR-98 in myocarditis and its influence on transcription of the FAS\/FASL gene pair. Genet Mol Res 2016;15.","DOI":"10.4238\/gmr.15027627"},{"key":"10277_CR13","first-page":"20135","volume":"8","author":"G Yang","year":"2015","unstructured":"Yang G, Zhang X, Shi J. MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1. Int J Clin Exp Med. 2015;8:20135\u201320145","journal-title":"Int J Clin Exp Med"},{"key":"10277_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.bbrc.2015.09.058","volume":"467","author":"HW Li","year":"2015","unstructured":"Li HW, Meng Y, Xie Q, Yi WJ, Lai XL, Bian Q, et al. miR-98 protects endothelial cells against hypoxia\/reoxygenation induced-apoptosis by targeting caspase-3. Biochem Biophys Res Commun. 2015;467:595\u2013601","journal-title":"Biochem Biophys Res Commun"},{"key":"10277_CR15","first-page":"3593","volume":"19","author":"YH Fan","year":"2015","unstructured":"Fan YH, Ye MH, Wu L, Lv SG, Wu MJ, Xiao B, et al. Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKepsilon. Eur Rev Med Pharmacol Sci. 2015;19:3593\u20133604","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10277_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jmb.2005.10.014","volume":"354","author":"JEZ Iga","year":"2005","unstructured":"Iga JEZ, Groppe JC, Cui Y, Hinck CS, Contreras-Shannon V, Pakhomova ON, et al. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. J Mol Biol. 2005;354:1052\u20131068","journal-title":"J Mol Biol"},{"key":"10277_CR17","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","volume":"24","author":"J Zavadil","year":"2005","unstructured":"Zavadil J, Ttinger BEP. TGF-|[beta]| and epithelial-to-mesenchymal transitions. Oncogene. 2005;24:5764","journal-title":"Oncogene"},{"key":"10277_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","volume":"29","author":"DP Ten","year":"2004","unstructured":"Ten DP, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci. 2004;29:265\u2013273","journal-title":"Trends Biochem Sci"},{"key":"10277_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76\u201399","journal-title":"J Cell Mol Med"},{"key":"10277_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685\u2013700","journal-title":"Cell"},{"key":"10277_CR21","first-page":"179","volume":"11","author":"F Jonathan","year":"2011","unstructured":"Jonathan F, Peter H. Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Clin Med (Lond). 2011;11:179\u2013183","journal-title":"Clin Med (Lond)"},{"key":"10277_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy \u2020. Hepatology. 2009;49:1017\u20131044","journal-title":"Hepatology"},{"key":"10277_CR23","doi-asserted-by":"publisher","first-page":"14568","DOI":"10.3748\/wjg.v20.i40.14568","volume":"20","author":"F Branchi","year":"2014","unstructured":"Branchi F, Conti CB, Baccarin A, Lampertico P, Fraquelli M. Non-invasive assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 2014;20:14568\u201314580","journal-title":"World J Gastroenterol"},{"key":"10277_CR24","doi-asserted-by":"crossref","unstructured":"Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X, Lu L. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection. Mol Med Rep. 2015.","DOI":"10.3892\/mmr.2015.4221"},{"key":"10277_CR25","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3748\/wjg.v17.i22.2748","volume":"17","author":"G Maubach","year":"2011","unstructured":"Maubach G, Lim M, Chen J, Yang H, Lang Z. miRNA studies in in vitro and in vivo activated hepatic stellate cells. World J Gastroenterol. 2011;17:2748\u20132773","journal-title":"World J Gastroenterol"},{"key":"10277_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","volume":"50","author":"CJ Guo","year":"2009","unstructured":"Guo CJ, Pan Q, Li DG, Sun H, Liu BW. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol. 2009;50:766\u2013778","journal-title":"J Hepatol"},{"key":"10277_CR27","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","volume":"24","author":"H Yong","year":"2012","unstructured":"Yong H, Huang C, Xu S, Long XR, Lv XW, Li J. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal. 2012;24:1923\u20131930","journal-title":"Cell Signal"},{"key":"10277_CR28","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.yexcr.2011.05.001","volume":"317","author":"C Chen","year":"2011","unstructured":"Chen C, Wu CQ, Zhang ZQ, Yao DK, Liang Z. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. EXP CELL RES. 2011;317:1714\u20131725","journal-title":"EXP CELL RES"},{"key":"10277_CR29","doi-asserted-by":"crossref","unstructured":"Feng X, Tan W, Si C, Wang H, Zhou Y. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-\u03baB pathway. DNA Cell Biol 2015; 34.","DOI":"10.1089\/dna.2014.2760"},{"key":"10277_CR30","doi-asserted-by":"crossref","unstructured":"Overexpression of miR-483\u20135p\/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-\u03b2 stimulated HSCs in transgenic mice. J Cell Mol Med 2014;18.","DOI":"10.1111\/jcmm.12293"},{"key":"10277_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2893.2011.01536.x","volume":"19","author":"O Waidmann","year":"2012","unstructured":"Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, et al. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepatitis. 2012;19:58\u201365","journal-title":"J Viral Hepatitis"},{"key":"10277_CR32","doi-asserted-by":"crossref","unstructured":"Roy S, B.F.V.C. (2015). miR\u201030c and miR\u2010193 are a part of the TGF\u2010\u03b2\u2010dependent regulatory network controlling extracellular matrix genes in liver fibrosis. J DIGEST DIS 16.","DOI":"10.1111\/1751-2980.12266"},{"key":"10277_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0672-0","volume":"13","author":"LEAHM Fang","year":"2015","unstructured":"Fang LEAHM. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015;13:1\u201312","journal-title":"J Transl Med"},{"key":"10277_CR34","doi-asserted-by":"publisher","first-page":"e1003291","DOI":"10.1371\/journal.pgen.1003291","volume":"9","author":"C Cardenas","year":"2013","unstructured":"Cardenas C, Henaoui IS, Courcot E, Roderburg C, Pottier N. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting Caveolin-1. PLOS Genet. 2013;9:e1003291","journal-title":"PLOS Genet"},{"key":"10277_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/mt.2014.42","volume":"22","author":"H Liang","year":"2014","unstructured":"Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, et al. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther. 2014;22:1122\u20131133","journal-title":"Mol Ther"},{"key":"10277_CR36","doi-asserted-by":"crossref","unstructured":"Jiang T, Li M, Li Q, Guo Z, Sun X, Zhang X, Liu Y, Yao W, Xiao P. MicroRNA-98\u20135p inhibits cell proliferation and induces cell apoptosis in hepatocellular carcinoma via targeting IGF2BP1. Oncol Res. 2016","DOI":"10.3727\/096504016X14821952695683"},{"key":"10277_CR37","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.18632\/oncotarget.717","volume":"3","author":"V Siragam","year":"2012","unstructured":"Siragam V, Rutnam ZJ, Yang W, Ling F, Yang BB. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget. 2012;3:1370\u20131385","journal-title":"Oncotarget"},{"key":"10277_CR38","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/jbmr.2753","volume":"31","author":"ML Ji","year":"2016","unstructured":"Ji ML, Lu J, Shi PL, Zhang XJ, Wang SZ, Chang Q, et al. Dysregulated miR-98 contributes to extracellular matrix degradation by targeting IL-6\/STAT3 signaling pathway in human intervertebral disc degeneration. J Bone Miner Res. 2016;31:900\u2013909","journal-title":"J Bone Miner Res"},{"key":"10277_CR39","first-page":"27","volume":"4","author":"R Safadi","year":"2002","unstructured":"Safadi R, Friedman SL. Hepatic fibrosis-role of hepatic stellate cell activation. MedGenMed. 2002;4:27","journal-title":"MedGenMed"},{"key":"10277_CR40","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","volume":"13","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia F, Mauviel A. Transforming growth factor-\u03b2 and fibrosis. World J Gastroenterol. 2007;13:3056\u20133062","journal-title":"World J Gastroenterol"},{"key":"10277_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/CS20110086","volume":"121","author":"JF Santibaez","year":"2011","unstructured":"Santibaez JF, Quintanilla M, Bernabeu C. TGF-beta\/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci. 2011;121:233\u2013251","journal-title":"Clin Sci"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10277-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10277-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10277-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T21:06:16Z","timestamp":1654635976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10277-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10277"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10277-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-520986\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-520986\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"18 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yanhua Ma, Xiaoxue Yuan, Ming Han, Yifan Xu, Kai Han, Pu Liang, Shunai Liu, Jun Chen, Huichun Xing declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No animal experiments were involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research (ethics)"}},{"value":"There is no conflict of interest to disclose. This is noted in the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (ethics)"}},{"value":"All authors agreed for publication in Hepatology International as an Article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish (ethics)"}},{"value":"<b>clinical trials registration<\/b> This study has passed the ethical review and obtained the approval of the ethical review (No. 2013\u2013061-2).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Plant reproducibility"}}]}}